Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer
Ontology highlight
ABSTRACT: This phase II trial is studying dasatinib to see how well it works in treating patients with previously treated metastatic colorectal cancer. Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for their growth.
DISEASE(S): Stage Iv Colon Cancer,Recurrent Colon Cancer,Rectal Neoplasms,Stage Iv Rectal Cancer,Recurrent Rectal Cancer,Colonic Neoplasms
PROVIDER: 2042300 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA